IND-SWIFT LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.6 INR | -2.22% |
|
-4.22% | +1.61% |
| 13/05 | Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
| 19/04 | Ind-Swift Laboratories to Incorporate Wholly-Owned Arm in Dubai | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 42.95B | ||||||
| 21.38B | ||||||
| 15.05B | ||||||
| 14.45B | ||||||
| 13.04B |
